The production potential of GenSci gradually began to exceed the needs of the state. The company began to expand the market and Jintropin went on sale to pharmacological distributors in the country. Which slowly began to spread “Jintropin” around the world. The relatively low price and the highest quality of the drug quickly made it popular; Especially popular “Jintropin” has become in the US, where it was used not only by ordinary citizens, but also “stars” of show business, wishing to push the threshold of aging, to tone up the decrepit muscles or get rid of excess fat under the skin. By the way, Madonna is almost his irreproachable physical form is responsible for “Jintropin”. “Jintropin” with might and main applied and sportsmen; One of the most famous – baseball player Barry Bonds.
And in early 2007, the whole world flew around the video footage, which was captured by Sylvester Stallone, trying to illegally bring his “Jintropin” into his country in the baggage on the day of the presentation of his film “Rocky Balboa” (“Rocky-6”) in Australia.
In the end, the number of detained “Jintropin” in aviation and seaports, postal parcels exceeded all conceivable and unthinkable volumes. Doping scandals with the withdrawal of the figurants precisely “Jintropin” became the most frequent news in sports and around sports circles. The patience of the US authorities has burst, and in 2007 they accused Lee Jin, who had been the head of GenSci all these years, in organizing a network of suppliers engaged in the illegal export of Jintropin to the United States. At one time there was even the question of Lee Jin’s extradition to the United States.
In these conditions, GenSci was forced to completely turn production – the state suspended the license for the release of “Jintropin” and withdrew the GMP certificate. And since the beginning of 2008 – in connection with the Olympic Games in Beijing – preparations of synthetic somatotropin were included in the list of especially controlled substances, which resulted in the termination of sales of these drugs in the pharmacy network. Please note: from the beginning of 2007 to the middle of 2010 GenSci did not produce “Jintropin” at all. That is, all the drugs that were at that time on the market were exceptionally fake.
In 2011, the production of “Jintropin” resumed, but that lesson learned very well in GenSci. The procedure for the release of the drug was seriously toughened. Now, only official distributors can purchase it for their country, which must have a license for the official sale of “Jintropin”, that is, the drug must go through official registration and certification.